Extendicare Inc.
EXETF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,271 | $1,191 | $1,110 | $933 |
| - Cash | $166 | $73 | $109 | $122 |
| + Debt | $337 | $284 | $287 | $292 |
| Enterprise Value | $1,443 | $1,403 | $1,288 | $1,104 |
| Revenue | $440 | $383 | $375 | $392 |
| % Growth | 14.8% | 2.3% | -4.3% | – |
| Gross Profit | $440 | $383 | $375 | $392 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | $49 | $54 | $32 | $41 |
| % Margin | 11.2% | 14.2% | 8.5% | 10.5% |
| Net Income | $24 | $32 | $15 | $20 |
| % Margin | 5.5% | 8.3% | 4% | 5.1% |
| EPS Diluted | 0.28 | 0.37 | 0.18 | 0.28 |
| % Growth | -24.3% | 105.6% | -35.7% | – |
| Operating Cash Flow | $64 | $53 | $18 | $18 |
| Capital Expenditures | -$10 | -$14 | -$15 | -$13 |
| Free Cash Flow | $54 | $39 | $3 | $4 |